Development Level

Tchem 2 | 1,388
Tclin 2 | 612
Tbio 1 | 11,651

Disease

Carcinoma 3 | 11,493
Cerebrovascular disease 3 | 238
Coronary artery disease 3 | 268
atypical teratoid / rhabdoid tumor 3 | 5,112
diabetes mellitus 3 | 1,728
intraductal papillary-mucinous carcinoma (IPMC) 3 | 2,989
medulloblastoma, large-cell 3 | 6,241
psoriasis 3 | 6,694
Astrocytoma, Pilocytic 2 | 3,081
Autosomal recessive predisposition 2 | 1,442
BLEEDING DISORDER, PLATELET-TYPE, 8 2 | 2
Chronic schizophrenia 2 | 16
Gastric ulcer 2 | 33
Schizophrenia 2 | 1,160
Seizures 2 | 596
Thrombosis 2 | 46
ductal carcinoma in situ 2 | 1,745
ependymoma 2 | 4,679
facioscapulohumeral dystrophy 2 | 288
glioblastoma 2 | 5,792
group 4 medulloblastoma 2 | 1,855
interstitial cystitis 2 | 2,312
intraductal papillary-mucinous adenoma (IPMA) 2 | 2,955
invasive ductal carcinoma 2 | 2,951
non-small cell lung cancer 2 | 2,890
oligodendroglioma 2 | 2,850
osteosarcoma 2 | 7,950
ovarian cancer 2 | 8,520
pancreatic cancer 2 | 2,398
platelet-type bleeding disorder 8 2 | 3
primitive neuroectodermal tumor 2 | 3,035
tuberculosis 2 | 2,010
Absence of secondary sex characteristics 1 | 22
Acanthosis Nigricans 1 | 27
Acute coronary syndrome 1 | 39
Alcohol withdrawal syndrome 1 | 20
Amenorrhea 1 | 58
Anovulation 1 | 21
Arteriosclerotic Parkinsonism 1 | 8
Arthritis, Experimental 1 | 39
Biliary dyskinesia 1 | 7
Bulimia nervosa 1 | 14
Cerebral embolism 1 | 3
Cycloplegia 1 | 12
Decreased T cell activation 1 | 4
Decreased serum leptin 1 | 6
Decreased testosterone in males 1 | 28
Dilated pupil 1 | 6
Enterocolitis 1 | 8
Extrapyramidal disease 1 | 8
General anesthesia 1 | 53
Gestational diabetes 1 | 26
Gynecomastia 1 | 64
Hemorrhage 1 | 19
Hyperglycemia 1 | 137
Hyperphagia 1 | 23
Hyperthyroidism 1 | 53
Hypertriglyceridemia result 1 | 37
Increased Urinary Frequency 1 | 11
Increased appetite (finding) 1 | 23
Infectious disease of lung 1 | 29
Insulin resistant diabetes 1 | 13
Iridocyclitis 1 | 19
Limb ischemia 1 | 15
Lipodystrophy 1 | 40
Low compliance bladder 1 | 11
Low serum estradiol levels 1 | 22
Memory Disorders 1 | 40
Metabolic Syndrome 1 | 20
Motion sickness 1 | 21
Multiple pulmonary infections 1 | 29
Nasal congestion 1 | 23
Nasal discharge 1 | 25
Neurotoxicity Syndromes 1 | 26
Non-Q wave myocardial infarction 1 | 4
Nonorganic psychosis 1 | 84
Obesity, Morbid 1 | 7
Oral Ulcer 1 | 15
Orthostatic hypotension due to autonomic dysfunction 1 | 5
Pelizaeus-Merzbacher disease 1 | 19
Peptic Ulcer 1 | 27
Peripheral Arterial Thromboembolism Prevention 1 | 2
Peripheral artery disease 1 | 10
Polydipsia 1 | 15
Polyuria 1 | 23
Postencephalitic parkinsonism 1 | 12
Prevention of Cerebral Thrombosis 1 | 29
Prevention of Motion Sickness 1 | 3
Prevention of Posterior Synechiae 1 | 4
Primary hypogonadism 1 | 37
Primary physiologic amenorrhea 1 | 55
Rabies 1 | 20
Recurrent pulmonary infections 1 | 29
Secondary hypothyroidism 1 | 15
Sinus bradycardia 1 | 7
Small testicle 1 | 75
Stomach Ulcer 1 | 18
Urgent desire to urinate 1 | 11
Uveitis 1 | 103
Vasomotor rhinitis 1 | 13

Tissue

Digestive Tract 5 | 17,369
Endocrine System 5 | 18,159
Female tissues 5 | 17,400
Liver and Pancreas 5 | 16,750
Male tissues 5 | 17,142
Nervous System 5 | 16,725
Respiratory system 5 | 16,393
Skin and soft tissues 5 | 17,230
Urinary Tract 5 | 16,678
Blood and immune system 4 | 16,909
Cardiovascular System 4 | 15,192

Target Family

GPCR 3 | 408
Ion Channel 1 | 344
Non-IDG 1 | 12,091

GO Process

positive regulation of ion tra... 5 | 5
transcription, DNA-templated 1,742 | 1,742
regulation of transcription, D... 1,135 | 1,135
G-protein coupled receptor sig... 1,053 | 1,053
signal transduction 1,005 | 1,005
positive regulation of transcr... 932 | 932
negative regulation of transcr... 683 | 683
positive regulation of transcr... 529 | 529
apoptotic process 511 | 511
cell differentiation 511 | 511
negative regulation of transcr... 492 | 492
neutrophil degranulation 484 | 484
negative regulation of apoptot... 479 | 479
positive regulation of cell pr... 470 | 470
innate immune response 469 | 469
multicellular organism develop... 460 | 460
cell adhesion 458 | 458
immune response 426 | 426
viral process 405 | 405
negative regulation of cell pr... 398 | 398
spermatogenesis 389 | 389
intracellular signal transduct... 376 | 376
inflammatory response 373 | 373
cell proliferation 366 | 366
post-translational protein mod... 356 | 356
protein transport 348 | 348
protein ubiquitination 347 | 347
cell division 345 | 345
regulation of transcription fr... 345 | 345
protein phosphorylation 334 | 334
nervous system development 321 | 321
positive regulation of apoptot... 320 | 320
response to drug 303 | 303
cell-cell signaling 300 | 300
positive regulation of gene ex... 297 | 297
transcription from RNA polymer... 286 | 286
protein deubiquitination 271 | 271
cell cycle 268 | 268
regulation of immune response 259 | 259
transport 255 | 255
regulation of apoptotic proces... 250 | 250
MAPK cascade 242 | 242
cell surface receptor signalin... 239 | 239
mRNA splicing, via spliceosome 236 | 236
protein polyubiquitination 222 | 222
angiogenesis 220 | 220
chemical synaptic transmission 219 | 219
cellular response to DNA damag... 217 | 217
proteolysis 217 | 217
proteasome-mediated ubiquitin-... 210 | 210
adaptive immune response 209 | 209
intracellular protein transpor... 209 | 209
DNA repair 206 | 206
leukocyte migration 206 | 206
protein homooligomerization 206 | 206
rRNA processing 204 | 204
extracellular matrix organizat... 198 | 198
visual perception 198 | 198
positive regulation of ERK1 an... 194 | 194
cellular protein metabolic pro... 192 | 192
brain development 188 | 188
axon guidance 186 | 186
Fc-epsilon receptor signaling ... 182 | 182
keratinization 182 | 182
cell migration 181 | 181
defense response to virus 181 | 181
positive regulation of cell mi... 179 | 179
regulation of cell proliferati... 177 | 177
in utero embryonic development 176 | 176
Wnt signaling pathway 175 | 175
cilium assembly 175 | 175
blood coagulation 170 | 170
RNA splicing 169 | 169
translation 169 | 169
mRNA processing 168 | 168
protein autophosphorylation 168 | 168
aging 167 | 167
response to hypoxia 166 | 166
T cell receptor signaling path... 164 | 164
heart development 164 | 164
negative regulation of canonic... 164 | 164
positive regulation of I-kappa... 164 | 164
ubiquitin-dependent protein ca... 164 | 164
ER to Golgi vesicle-mediated t... 162 | 162
protein stabilization 160 | 160
response to lipopolysaccharide 160 | 160
transcription initiation from ... 160 | 160
defense response to bacterium 159 | 159
protein folding 159 | 159
sensory perception of smell 157 | 157
homophilic cell adhesion via p... 156 | 156
transmembrane transport 154 | 154
negative regulation of gene ex... 151 | 151
interferon-gamma-mediated sign... 150 | 150
receptor-mediated endocytosis 150 | 150
ion transmembrane transport 148 | 148
peptidyl-serine phosphorylatio... 148 | 148
positive regulation of protein... 148 | 148
antigen processing and present... 143 | 143
DNA replication 142 | 142
cell cycle arrest 142 | 142

This is where graphics are reside..
Name Gene Development Level Target Family Log Novelty  Pubmed Score  Antibody Count  Knowledge Availability 
P2X purinoceptor 1 P2RX1 Tchem Ion Channel -2.41145 259.4 137
P2Y purinoceptor 12 P2RY12 Tclin GPCR -3.19274 1507.4 135
P2Y purinoceptor 1 P2RY1 Tchem GPCR -2.55590 345.6 255
Muscarinic acetylcholine receptor M1 CHRM1 Tclin GPCR -2.16159 140.8 222
Leptin LEP Tbio Non-IDG -4.17777 16050.7 1012